Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)

PHASE3CompletedINTERVENTIONAL
Enrollment

515

Participants

Timeline

Start Date

June 6, 2019

Primary Completion Date

May 13, 2020

Study Completion Date

May 29, 2020

Conditions
Plaque Psoriasis
Interventions
DRUG

Tapinarof

Tapinarof cream, 1%, applied once daily

DRUG

Vehicle Cream

Vehicle cream applied once daily

Trial Locations (50)

11790

Dermavant Investigative Site, Stony Brook

23502

Dermavant Investigative Site, Norfolk

27157

Dermavant Investigative Site, Winston-Salem

28405

Dermavant Investigative Site, Wilmington

29414

Dermavant Investigative Site, Charleston

33144

Dermavant Investigative Site, Miami

33414

Dermavant Investigative Site, Margate

33437

Dermavant Investigative Site, Boynton Beach

37215

Dermavant Investigative Site, Nashville

40217

Dermavant Investigative Site, Louisville

42301

Dermavant Investigative Site, Owensboro

43209

Dermavant Investigative Site, Bexley

44122

Dermavant Investigative Site, Beachwood

46168

Dermavant Investigative Site, Plainfield

48059

Dermavant Investigative Site, Fort Gratiot

48202

Dermavant Investigative Site, Detroit

48706

Dermavant Investigative Site, Bay City

55432

Dermavant Investigative Site, Fridley

60008

Dermavant Investigative Site, Rolling Meadows

66215

Dermavant Investigative Site, Overland Park

68144

Dermavant Investigative Site, Omaha

70006

Dermavant Investigative Site, Metairie

72916

Dermavant Investigative Site, Fort Smith

75024

Dermavant Investigative Site, Plano

77056

Dermavant Investigative Site, Houston

77598

Dermavant Investigative Site, Webster

78229

Dermavant Investigative Site, San Antonio

78660

Dermavant Investigative Site, Pflugerville

80210

Dermavant Investigative Site, Denver

83713

Dermavant Investigative Site, Boise

89148

Dermavant Investigative Site, Las Vegas

90045

Dermavant Investigative Site, Los Angeles

90404

Dermavant Investigative Site, Santa Monica

92056

Dermavant Investigative Site, Oceanside

92123

Dermavant Investigative Site, San Diego

92708

Dermavant Investigative Site, Fountain Valley

94538

Dermavant Investigative Site, Fremont

97223

Dermavant Investigative Site, Portland

99202

Dermavant Investigative Site, Spokane

02215

Dermavant Investigative Site, Boston

08520

Dermavant Investigative Site, East Windsor

07601

Dermavant Investigative Site, Hackensack

T5K 1X3

Dermavant Investigative Site, Edmonton

V3R 6A7

Dermavant Investigative Site, Surrey

V3V 0C6

Dermavant Investigative Site, Surrey

M9A 3P2

Dermavant Investigative Site, Etobicoke

L8N 1Y2

Dermavant Investigative Site, Hamilton

L3P 1X2

Dermavant Investigative Site, Markham

L6J 7W5

Dermavant Investigative Site, Oakville

K2C 3N2

Dermavant Investigative Site, Ottawa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

IQVIA Biotech

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT03983980 - Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) | Biotech Hunter | Biotech Hunter